Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Arrowhead Pharma (NQ: ARWR)
56.42 USD  -0.69 (-1.21%)
Official Closing Price  /  Updated: 6:16 PM EST, Jan 17, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,541,500
Open 57.69
Bid (Size) 56.00 (1)
Ask (Size) 56.55 (1)
Prev. Close 57.11
Today's Range 56.11 - 57.69
52wk Range 12.51 - 73.72
Shares Outstanding 87,577,188
Dividend Yield N/A
Performance
YTD
-10.61%
-10.61%
1 Month
-15.17%
-15.17%
3 Month
+56.94%
+56.94%
6 Month
+93.42%
+93.42%
1 Year
+285.65%
+285.65%
Top News
More News
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Arrowhead Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of... Read More
from PR Newswire
Arrowhead Pharmaceuticals Appoints James Hassard as Chief Commercial Officer
Arrowhead hires James Hassard as Chief Commercial Officer Read More
from Business Wire News Releases
More News
Read More
Live Nation Entertainment, Zebra Technologies, STERIS Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
from PR Newswire
Noteworthy ETF Outflows: IWM, NVCR, GNRC, ARWR
category ETFs
from ETF Channel
Arrowhead Pharmaceuticals Doses First Patient in AROAAT2002 Open Label Phase 2 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease
from Business Wire News Releases
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
from Business Wire News Releases
SLYG, ARWR, NEOG, CBU: ETF Outflow Alert
category ETFs
from ETF Channel
Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1 Study of ARO-HSD for Treatment of Alcohol and Nonalcohol Related Liver Disease
from Business Wire News Releases
Arrowhead Pharmaceuticals Appoints Marianne De Backer to Board of Directors
from Business Wire News Releases
First Week of ARWR February 2020 Options Trading
category Stocks
from Market News Video
Here's Why Arrowhead Pharmaceuticals Stock Soared 410% in 2019
category Market News , JNJ , ARWR
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.